BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 770209)

  • 1. [Evaluation of the physiological availability of drug substances in capsules].
    Mikhaĭlova GS
    Farmatsiia; 1975; 24(1):78-82. PubMed ID: 770209
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gelatin capsules].
    Griadunova GP; Litvinova TP; Davigora IV
    Farmatsiia; 1975; 24(4):72-7. PubMed ID: 767147
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of biopharmaceutical parameters in drug development (author's transl)].
    Thoma K
    Arzneimittelforschung; 1976; 26(1A):121-9. PubMed ID: 947191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug product equivalence--are specifications necessary?
    Bergen JV
    J Am Pharm Assoc; 1972 Jan; 12(1):21-5. PubMed ID: 5007259
    [No Abstract]   [Full Text] [Related]  

  • 5. [Medicinal capsules].
    Khanina GI; Batkina ZV; Pospelova VV; Dedukh NG
    Farmatsiia; 1974; (6):67-70. PubMed ID: 4618815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bioavailability of peroral antibiotic preparations].
    Zak AF
    Antibiotiki; 1977 Mar; 22(3):265-79. PubMed ID: 322606
    [No Abstract]   [Full Text] [Related]  

  • 7. Some aspects of the influence of formulation on the bioavailability of drugs from solid dosage forms.
    Corrigan OI; Timoney RF
    Ir J Med Sci; 1974 Jul; 143(4):197-207. PubMed ID: 4605123
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceutical sciences--1973: literature review of pharmaceutics.
    Herd AK; Haleblian JK
    J Pharm Sci; 1974 Jul; 63(7):995-1055. PubMed ID: 4604899
    [No Abstract]   [Full Text] [Related]  

  • 9. Generic omeprazole delayed-release capsules: in vitro performance evaluations.
    Moore T; Smith A; Ye W; Toler DY; Westenberger BJ; Lionberger R; Raw A; Yu L; Buhse LF
    Drug Dev Ind Pharm; 2009 Aug; 35(8):917-21. PubMed ID: 19555236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical sciences--1972: literature review of pharmaceutics. I.
    Shah AC; Herd AK
    J Pharm Sci; 1973 Jul; 62(7):1033-65. PubMed ID: 4581952
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectivness prolongation of drugs with special consideration for peroral depot drug forms].
    Hänselmann B; Voigt R
    Pharmazie; 1971 Feb; 26(2):57-77. PubMed ID: 4930108
    [No Abstract]   [Full Text] [Related]  

  • 12. USP standards for dissolution and bioavailability.
    Grady LT
    Am J Hosp Pharm; 1982 Sep; 39(9):1546-8. PubMed ID: 7137198
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of auxiliary substances on the bioavailability of tetracycline hydrochloride capsules (an in vitro study)].
    Grakovskaia LK; Nesterova LIa; Okhotnikova VF; Zak AF; Ermolova OB
    Antibiotiki; 1978 Mar; 23(3):215-9. PubMed ID: 637528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability and bioequivalence.
    Skelly JP
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):539-45. PubMed ID: 977792
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biopharmacy and pharmacopoeias].
    Mirimanoff A
    Pharm Acta Helv; 1971 Mar; 46(3):129-33. PubMed ID: 5550116
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro evaluation of extemporaneously compounded immediate-release capsules with premixed excipients, based on the biopharmaceutics classification system (BCS) of the drugs.
    Pinheiro VA; Danopoulos P; Demirdjian L; Nogueira RJ; Dubois F
    Int J Pharm Compd; 2013; 17(5):424-31. PubMed ID: 24459788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bioavailability, proof of efficacy and their consequences for drug legislation (author's transl)].
    Schnieders B
    Arzneimittelforschung; 1976; 26(1A):158-63. PubMed ID: 947195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ointments. VIII. Release of antibiotics from ointment bases of varying chemical nature].
    Pertsev IM; Bashura GS; Piatikop AI; Aliushin MT
    Farm Zh; 1974; 29(2):42-9. PubMed ID: 4463053
    [No Abstract]   [Full Text] [Related]  

  • 19. [Injection casting procedure for the preparation of oral delayed-action preparations. 4. Break-in of channeling pharmaceutic aids].
    Hüttenrauch R; Schmeiss U
    Pharmazie; 1976 Jul; 31(7):471-4. PubMed ID: 981302
    [No Abstract]   [Full Text] [Related]  

  • 20. Some dissolution aspects of ferrous sulfate tablets.
    Blezek CE; Lach JL; Guillory JK
    Am J Hosp Pharm; 1970 Jul; 27(7):533-9. PubMed ID: 5431051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.